TVRD
Tvardi Therapeutics
TVRD
TVRD
121 hedge funds and large institutions have $222M invested in Tvardi Therapeutics in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 35 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 35
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
46% less call options, than puts
Call options by funds: $3.9M | Put options by funds: $7.22M
Holders
121
Holding in Top 10
1
Calls
$3.9M
Puts
$7.22M
Top Buyers
| 1 | +$7.96M | |
| 2 | +$4.35M | |
| 3 | +$2.49M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.73M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.11M |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$1.8M | |
| 3 | -$1.37M | |
| 4 |
Squarepoint
New York
|
-$1.08M |
| 5 |
Goldman Sachs
New York
|
-$602K |